Fabrizio Pertusati

Years Active: 2017-2024
Publications (10 Years): 7

Cardiff University

Università degli Studi di Torino (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cardiff University Apr 01 2011 - Dec 31 2018

United Kingdom

Lecturer in Medicinal Chemistry :: School of Pharmacy

Education History

Università degli Studi di Torino

Italy

MSC :: Chimica Generale and Organica Applicata

Cardiff University Aug 01 2005 - Oct 01 2008

United Kingdom

PHD :: School of Chemistry

Publications

Raed Alghamdi, Fabrizio Pertusati, Polina Prokopovich
Poly-beta-amino-ester licofelone conjugates development for osteoarthritis treatment. RSC advances 14 (1) (2024)
Raed Alghamdi, Fabrizio Pertusati, Polina Prokopovich
Poly-beta-amino-ester licofelone conjugates development for osteoarthritis treatment. RSC advances 14 (1) (2024)
Raed Alghamdi, Fabrizio Pertusati, Polina Prokopovich
Poly-beta-amino-ester licofelone conjugates development for osteoarthritis treatment. RSC advances 14 (1) (2024)
Raed Alghamdi, Fabrizio Pertusati, Polina Prokopovich
Poly-beta-amino-ester licofelone conjugates development for osteoarthritis treatment. RSC advances 14 (1) (2024)
Raed Alghamdi, Fabrizio Pertusati, Polina Prokopovich
Poly-beta-amino-ester licofelone conjugates development for osteoarthritis treatment. RSC advances 14 (1) (2024)
Chiara Morozzi, Jana Sedláková, Michaela Serpi, Marialuce Avigliano, Rosangela Carbajo, Lucia Sandoval, Yadira Valles-Ayoub, Patrick Crutcher, Stephen Thomas, Fabrizio Pertusati
Targeting GNE Myopathy: A Dual Prodrug Approach for the Delivery of N-Acetylmannosamine 6-Phosphate. Journal of medicinal chemistry 62 (17) (2019)
Marcella Bassetto, Salvatore Ferla, Gilda Giancotti, Fabrizio Pertusati, Andrew D Westwell, Andrea Brancale, Christopher McGuigan
Rational design and synthesis of novel phenylsulfonyl-benzamides as anti-prostate cancer agents. MedChemComm 8 (7) (2017)

Fabrizio Pertusati.css-eqlu8i{font-size:small;padding-left:4px;}